Innovations in Plasma-Derived Therapies Strengthen the Biopharmaceutical Landscape
The Blood Plasma Market is entering a period of sustained industry development as an aging population, rising chronic diseases, expanding healthcare infrastructure, and greater access to plasma-derived therapies. Valued at USD 34.09 billion in 2025, the market is projected to reach USD 36.55 billion in 2026 and USD 63.74 billion by 2034, registering a CAGR of 7.20% during the forecast period...
0 Reacties 0 aandelen 2 Views 0 voorbeeld
AC Mingle https://acmingle.com